With the much-awaited Fed meeting also coming up next week ... If the drug succeeds, it could offer robust competition to major pharmaceutical companies such as Novo Nordisk and Eli Lilly, especially ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

The Dimensional US Core Equity 1 ETF offers a strong balance of growth and value stocks, making it a solid choice for ...